328 related articles for article (PubMed ID: 20519411)
1. Equol: pharmacokinetics and biological actions.
Setchell KD; Clerici C
J Nutr; 2010 Jul; 140(7):1363S-8S. PubMed ID: 20519411
[TBL] [Abstract][Full Text] [Related]
2. Equol: history, chemistry, and formation.
Setchell KD; Clerici C
J Nutr; 2010 Jul; 140(7):1355S-62S. PubMed ID: 20519412
[TBL] [Abstract][Full Text] [Related]
3. S-equol, a potent ligand for estrogen receptor beta, is the exclusive enantiomeric form of the soy isoflavone metabolite produced by human intestinal bacterial flora.
Setchell KD; Clerici C; Lephart ED; Cole SJ; Heenan C; Castellani D; Wolfe BE; Nechemias-Zimmer L; Brown NM; Lund TD; Handa RJ; Heubi JE
Am J Clin Nutr; 2005 May; 81(5):1072-9. PubMed ID: 15883431
[TBL] [Abstract][Full Text] [Related]
4. The pharmacokinetic behavior of the soy isoflavone metabolite S-(-)equol and its diastereoisomer R-(+)equol in healthy adults determined by using stable-isotope-labeled tracers.
Setchell KD; Zhao X; Jha P; Heubi JE; Brown NM
Am J Clin Nutr; 2009 Oct; 90(4):1029-37. PubMed ID: 19710188
[TBL] [Abstract][Full Text] [Related]
5. The clinical importance of the metabolite equol-a clue to the effectiveness of soy and its isoflavones.
Setchell KD; Brown NM; Lydeking-Olsen E
J Nutr; 2002 Dec; 132(12):3577-84. PubMed ID: 12468591
[TBL] [Abstract][Full Text] [Related]
6. S-(-)equol producing status not associated with breast cancer risk among low isoflavone-consuming US postmenopausal women undergoing a physician-recommended breast biopsy.
Virk-Baker MK; Barnes S; Krontiras H; Nagy TR
Nutr Res; 2014 Feb; 34(2):116-25. PubMed ID: 24461312
[TBL] [Abstract][Full Text] [Related]
7. Metabolism of dietary soy isoflavones to equol by human intestinal microflora--implications for health.
Yuan JP; Wang JH; Liu X
Mol Nutr Food Res; 2007 Jul; 51(7):765-81. PubMed ID: 17579894
[TBL] [Abstract][Full Text] [Related]
8. Potential Protective Mechanisms of S-equol, a Metabolite of Soy Isoflavone by the Gut Microbiome, on Cognitive Decline and Dementia.
Sekikawa A; Wharton W; Butts B; Veliky CV; Garfein J; Li J; Goon S; Fort A; Li M; Hughes TM
Int J Mol Sci; 2022 Oct; 23(19):. PubMed ID: 36233223
[TBL] [Abstract][Full Text] [Related]
9. S-(-)equol production is developmentally regulated and related to early diet composition.
Brown NM; Galandi SL; Summer SS; Zhao X; Heubi JE; King EC; Setchell KD
Nutr Res; 2014 May; 34(5):401-9. PubMed ID: 24916553
[TBL] [Abstract][Full Text] [Related]
10. Method of defining equol-producer status and its frequency among vegetarians.
Setchell KD; Cole SJ
J Nutr; 2006 Aug; 136(8):2188-93. PubMed ID: 16857839
[TBL] [Abstract][Full Text] [Related]
11. The pharmacokinetics of S-(-)equol administered as SE5-OH tablets to healthy postmenopausal women.
Setchell KD; Zhao X; Shoaf SE; Ragland K
J Nutr; 2009 Nov; 139(11):2037-43. PubMed ID: 19776178
[TBL] [Abstract][Full Text] [Related]
12. Bacterial communities and metabolic activity of faecal cultures from equol producer and non-producer menopausal women under treatment with soy isoflavones.
Guadamuro L; Dohrmann AB; Tebbe CC; Mayo B; Delgado S
BMC Microbiol; 2017 Apr; 17(1):93. PubMed ID: 28415978
[TBL] [Abstract][Full Text] [Related]
13. Daidzein and genistein are converted to equol and 5-hydroxy-equol by human intestinal Slackia isoflavoniconvertens in gnotobiotic rats.
Matthies A; Loh G; Blaut M; Braune A
J Nutr; 2012 Jan; 142(1):40-6. PubMed ID: 22113864
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics of equol, a soy isoflavone metabolite, changes with the form of equol (dietary versus intestinal production) in ovariectomized rats.
Legette LL; Prasain J; King J; Arabshahi A; Barnes S; Weaver CM
J Agric Food Chem; 2014 Feb; 62(6):1294-300. PubMed ID: 24446705
[TBL] [Abstract][Full Text] [Related]
15. Soy isoflavone-specific biotransformation product S-equol in the colon: physiological functions, transformation mechanisms, and metabolic regulatory pathways.
Wang X; Chen B; Fang X; Zhong Q; Liao Z; Wang J; Wu X; Ma Y; Li P; Feng X; Wang L
Crit Rev Food Sci Nutr; 2024; 64(16):5462-5490. PubMed ID: 36503364
[TBL] [Abstract][Full Text] [Related]
16. Potential Protective Effects of Equol (Soy Isoflavone Metabolite) on Coronary Heart Diseases-From Molecular Mechanisms to Studies in Humans.
Zhang X; Veliky CV; Birru RL; Barinas-Mitchell E; Magnani JW; Sekikawa A
Nutrients; 2021 Oct; 13(11):. PubMed ID: 34835997
[TBL] [Abstract][Full Text] [Related]
17. The role of soy isoflavones in menopausal health: report of The North American Menopause Society/Wulf H. Utian Translational Science Symposium in Chicago, IL (October 2010).
North American Menopause Society
Menopause; 2011 Jul; 18(7):732-53. PubMed ID: 21685820
[TBL] [Abstract][Full Text] [Related]
18. Gut bacterial metabolism of the soy isoflavone daidzein: exploring the relevance to human health.
Atkinson C; Frankenfeld CL; Lampe JW
Exp Biol Med (Maywood); 2005 Mar; 230(3):155-70. PubMed ID: 15734719
[TBL] [Abstract][Full Text] [Related]
19. Metabolism of Soy Isoflavones by Intestinal Bacteria: Genome Analysis of an
Vázquez L; Flórez AB; Redruello B; Mayo B
Biomolecules; 2020 Jun; 10(6):. PubMed ID: 32586036
[TBL] [Abstract][Full Text] [Related]
20. The chemopreventive action of equol enantiomers in a chemically induced animal model of breast cancer.
Brown NM; Belles CA; Lindley SL; Zimmer-Nechemias LD; Zhao X; Witte DP; Kim MO; Setchell KD
Carcinogenesis; 2010 May; 31(5):886-93. PubMed ID: 20110282
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
